Dupont Nutrition Biosciences Aps

Heli Putaala

Rodolphe Barrangou

Karsten Matthias Kragh

Andrei Miasnikov

Shukun Yu

Nina Rautonen

Kirsti Tiihonen

Sampo Lahtinen

Didier Carcano

Pierre Desreumaux

Rémy Burcelin

Arthur Ouwehand

Luis Fernando Romero Millan

Luke Barnard

Svend Haaning

Ernst Meinjohanns

Steffen Yde Bak

Stepan Shipovskov

Päivi Nurminen

Marta Korczynska

Wouter Herman Noordman

Maria Ma

Marta Zdzislawa Korczynska

The invention relates to use of a bacterium selected from a lactic acid bacterium, aor a mixture of any thereof for treating metabolic endotoxemia, inhibiting bacterial translocation and regulating lipid absorption in a mammal.

Lactic acid bacteria andfor treating endotoxemia

Lactic acid bacteria and bifidobacteria for treating endotoxemia

Use of at least one strain of a microorganism and/or a metabolite thereof in the manufacture of a support for administration to a subject for modulating satiety signalling, wherein the support is a pharmaceutically acceptable support or a food product. Suitably, the at least one strain of a microorganism and/or a metabolite thereof may be administered to the subject for the treatment and/or prevention of excess weight and/or a disease caused by excess weight. Likewise, the at least one strain of a microorganism and/or a metabolite thereof is administered to the subject for the treatment and/or prevention of obesity and/or a caused by obesity. Preferably, the microorganism is a probiotic microorganism. Suitably the microorganism may be a lactic acid bacterium. Li one embodiment the microorganism is a strain ofspp. and/orspp., for example a strain ofand/or

[object Object]

Growing community of inventors

Kirkkonummi, Finland

Heli Putaala